Page last updated: 2024-10-29

ketoconazole and Adrenal Cortex Neoplasms

ketoconazole has been researched along with Adrenal Cortex Neoplasms in 24 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Adrenal Cortex Neoplasms: Tumors or cancers of the ADRENAL CORTEX.

Research Excerpts

ExcerptRelevanceReference
"The property of ketoconazole to inhibit adrenal biosynthesis of cortisol was used in a clinical study of 14 patients with Cushing's syndrome (pituitary-dependent Cushing's disease, n = 10; adrenocortical adenoma, n = 2; adrenocortical carcinoma, n = 1; ectopic ACTH syndrome, n = 1)."9.06Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome. ( Doerr, HG; Engelhardt, D; Jacob, K, 1989)
" We report a patient with Cushing's syndrome due to adrenocortical adenoma who became pregnant and was successfully treated with ketoconazole during the last period of pregnancy."7.68Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. ( Alvarez, A; Amado, JA; Freijanes, J; Gonzalez, EM; Otero, M; Pesquera, C, 1990)
"Mild Cushing's syndrome was diagnosed in a 35 year old woman."5.27Primary adrenocortical micronodular adenomatosis causing Cushing's syndrome. Effects of ketoconazole on steroid production and in vitro performance of adrenal cells. ( Bähr, V; Hensen, J; Oelkers, W; Pickartz, H, 1986)
"The property of ketoconazole to inhibit adrenal biosynthesis of cortisol was used in a clinical study of 14 patients with Cushing's syndrome (pituitary-dependent Cushing's disease, n = 10; adrenocortical adenoma, n = 2; adrenocortical carcinoma, n = 1; ectopic ACTH syndrome, n = 1)."5.06Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome. ( Doerr, HG; Engelhardt, D; Jacob, K, 1989)
" We report a patient with Cushing's syndrome due to adrenocortical adenoma who became pregnant and was successfully treated with ketoconazole during the last period of pregnancy."3.68Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. ( Alvarez, A; Amado, JA; Freijanes, J; Gonzalez, EM; Otero, M; Pesquera, C, 1990)
"Cushing's syndrome is a complex endocrine condition with potential serious complications if untreated or inadequately treated."2.45Drugs in the medical treatment of Cushing's syndrome. ( Schteingart, DE, 2009)
"Unfortunately the patient died of respiratory failure due to metastasis."1.37[Bilateral conjunctival oedema as a symptom of adrenal adenocarcinoma]. ( Montes-Mollón, MÁ; Paz Moreno-Arrones, J, 2011)
"Aminoglutethimide was examined only for effects on CYP11A activity and was shown to inhibit pregnenolone formation (20 microM: 61 +/- 4% of control)."1.31Effects of 3-MeSO2-DDE and some CYP inhibitors on glucocorticoid steroidogenesis in the H295R human adrenocortical carcinoma cell line. ( Johansson, MK; Lund, BO; Sanderson, JT, 2002)
" Twenty dogs with hyperadrenocorticism (11 with PDH, 9 with adrenocortical tumor) were treated with ketoconazole at a dosage of 15 mg/kg given every 12 hours for a half month to 12 months."1.28Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism. ( Bruyette, DS; Farver, TB; Feldman, EC; Nelson, RW, 1990)
"Mild Cushing's syndrome was diagnosed in a 35 year old woman."1.27Primary adrenocortical micronodular adenomatosis causing Cushing's syndrome. Effects of ketoconazole on steroid production and in vitro performance of adrenal cells. ( Bähr, V; Hensen, J; Oelkers, W; Pickartz, H, 1986)

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19906 (25.00)18.7374
1990's11 (45.83)18.2507
2000's4 (16.67)29.6817
2010's3 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delivanis, DA1
Athimulam, S1
Bancos, I1
Schteingart, DE1
Paz Moreno-Arrones, J1
Montes-Mollón, MÁ1
Dutta, D1
Jain, R1
Maisnam, I1
Mishra, PK1
Ghosh, S1
Mukhopadhyay, S1
Chowdhury, S1
Carmona-Bayonas, A1
Soler, IO1
Gómez, FI1
Billalabeitia, EG1
Saura, HP1
Tafalla, MS1
Díaz, MP1
Kowal, J1
Miller, JW1
Crapo, L1
Rosenthal, KL1
Quesenberry, KE1
Peterson, ME2
Archambeaud-Mouveroux, F1
Miossec, P1
Teissier, MP1
Vieira, JC1
Descottes, B1
Höfle, G1
Gasser, RW1
Lhotta, K1
Janetschek, G1
Kreczy, A1
Finkenstedt, G1
Behrend, EN1
Kemppainen, RJ1
Clark, TP1
Salman, MD1
Neto, LS1
Filho, AG1
Bustorff-Silva, JM1
Köler, H1
Epelman, S1
Marini, SH1
Júnior, GG1
Johansson, MK1
Sanderson, JT1
Lund, BO1
Harinarayan, CV1
Gupta, S1
Ammini, AC1
Karmarkar, MG1
Gupta, R1
Sharma, LK1
Ahuja, MM1
Kruimel, JW1
Smals, AG1
Beex, LV1
Swinkels, LM1
Pieters, GF1
Kloppenborg, PW1
Nichols, R1
Saadi, HF1
Bravo, EL1
Aron, DC1
Amado, JA1
Pesquera, C1
Gonzalez, EM1
Otero, M1
Freijanes, J1
Alvarez, A1
Feldman, EC1
Bruyette, DS1
Nelson, RW1
Farver, TB1
Engelhardt, D1
Jacob, K1
Doerr, HG1
Sinnaeve, LJ1
Becks, GP1
Verhelst, JA1
Druwé, P1
van Erps, P1
Denis, LJ1
Mahler, C1
Feve, B1
Bauduceau, B1
Lefebvre, H1
Garcin, JM1
Gautier, D1
Oelkers, W1
Bähr, V1
Hensen, J1
Pickartz, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Open-label Study of the Efficacy and Safety of CORLUX (Mifepristone) in the Treatment of the Signs and Symptoms of Endogenous Cushing's Syndrome[NCT00569582]Phase 350 participants (Actual)Interventional2007-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Decrease in Diastolic Blood Pressure.

Responder is defined as subject with a decrease greater than or equal to 5mm Hg in diastolic blood pressure from baseline to week 24 or last visit. (NCT00569582)
Timeframe: Baseline to Week 24

Interventionparticipants (Number)
Mifepristone8

Improvement in Diabetes and/or Glucose Intolerance.

Responder is defined as subject with a decrease greater than or equal to 25% in area under the curve for glucose on 2-hour oral glucose test from baseline to week 24 or last visit, for Cushing's patients with type-2 diabetes mellitus/impaired glucose tolerance. (NCT00569582)
Timeframe: Baseline to Week 24

Interventionparticipants (Number)
Mifepristone15

Reviews

3 reviews available for ketoconazole and Adrenal Cortex Neoplasms

ArticleYear
Drugs in the medical treatment of Cushing's syndrome.
    Expert opinion on emerging drugs, 2009, Volume: 14, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Antiparkinson Agents; Cabergoline; Cushing Sy

2009
The medical treatment of Cushing's syndrome.
    Endocrine reviews, 1993, Volume: 14, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Aminoglutethimide; Animals; Bromocriptine; Cushing Syndrom

1993
Problems associated with medical therapy of canine hyperadrenocorticism.
    Problems in veterinary medicine, 1990, Volume: 2, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Animals; Cushing Syndrome; Diabetes Mellitus

1990

Trials

1 trial available for ketoconazole and Adrenal Cortex Neoplasms

ArticleYear
Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.
    Klinische Wochenschrift, 1989, Feb-15, Volume: 67, Issue:4

    Topics: ACTH Syndrome, Ectopic; Adenoma; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Cushi

1989

Other Studies

20 other studies available for ketoconazole and Adrenal Cortex Neoplasms

ArticleYear
Modern Management of Mild Autonomous Cortisol Secretion.
    Clinical pharmacology and therapeutics, 2019, Volume: 106, Issue:6

    Topics: 14-alpha Demethylase Inhibitors; Adrenal Cortex Neoplasms; Adrenal Insufficiency; Adrenalectomy; Adr

2019
[Bilateral conjunctival oedema as a symptom of adrenal adenocarcinoma].
    Archivos de la Sociedad Espanola de Oftalmologia, 2011, Volume: 86, Issue:6

    Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aged; Antineoplastic Combined Chemotherapy

2011
Isolated Cushing's syndrome in early infancy due to left adrenal adenoma: an unusual aetiology.
    Journal of clinical research in pediatric endocrinology, 2012, Volume: 4, Issue:3

    Topics: 14-alpha Demethylase Inhibitors; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Ad

2012
Tailored hormonal therapy in secretory adrenocortical cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:7

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Ang

2007
The effect of ketoconazole on steroidogenesis in cultured mouse adrenal cortex tumor cells.
    Endocrinology, 1983, Volume: 112, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Animals; Antifungal Agents; Cells, Cultured;

1983
Questions about assays used for estradiol 1-17 beta.
    Journal of the American Veterinary Medical Association, 1994, Apr-01, Volume: 204, Issue:7

    Topics: Adrenal Cortex Neoplasms; Animals; Estradiol; Female; Ferrets; Ketoconazole; Male; Radioimmunoassay;

1994
[Malignant adrenocortical carcinoma and ketoconazole].
    La Revue de medecine interne, 1993, Volume: 14, Issue:7

    Topics: Adrenal Cortex Neoplasms; Adult; Female; Humans; Ketoconazole

1993
Adrenocortical carcinoma evolving after diagnosis of preclinical Cushing's syndrome in an adrenal incidentaloma. A case report.
    Hormone research, 1998, Volume: 50, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Androgens; Antineoplastic Combined Chemotherapy Prot

1998
Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
    Journal of the American Veterinary Medical Association, 1999, Oct-01, Volume: 215, Issue:7

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone;

1999
Pre-operative control of arterial hypertension using ketoconazole in pediatric patients with adrenocortical tumors.
    Journal of pediatric endocrinology & metabolism : JPEM, 2000, Volume: 13, Issue:2

    Topics: Adrenal Cortex Neoplasms; Child, Preschool; Humans; Hypertension; Infant; Ketoconazole; Male; Preope

2000
Effects of 3-MeSO2-DDE and some CYP inhibitors on glucocorticoid steroidogenesis in the H295R human adrenocortical carcinoma cell line.
    Toxicology in vitro : an international journal published in association with BIBRA, 2002, Volume: 16, Issue:2

    Topics: Adrenal Cortex Neoplasms; Aminoglutethimide; Carcinoma; Chromatography, High Pressure Liquid; Colfor

2002
Clinical utility of ketoconazole in cases of adrenocortical carcinoma.
    Indian journal of cancer, 1991, Volume: 28, Issue:4

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adult; Child; Female; Humans; Ketoconazole; Male

1991
Favourable response of a virilizing adrenocortical carcinoma to preoperative treatment with ketoconazole and postoperative chemotherapy.
    Acta endocrinologica, 1991, Volume: 124, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adult; Aldehyde-Lyases; Androgens; Antineoplastic Combined Chemotherapy Pr

1991
Feminizing adrenocortical tumor: steroid hormone response to ketoconazole.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 70, Issue:2

    Topics: 17-Ketosteroids; Adrenal Cortex Neoplasms; Aldosterone; Androgen-Insensitivity Syndrome; Corticoster

1990
Successful treatment with ketoconazole of Cushing's syndrome in pregnancy.
    Postgraduate medical journal, 1990, Volume: 66, Issue:773

    Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Cushing Syndrome; Female; Humans; Ketoconazole; Pregnancy;

1990
Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
    Journal of the American Veterinary Medical Association, 1990, Jul-01, Volume: 197, Issue:1

    Topics: Adenoma; Administration, Oral; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Animals; Carc

1990
Preoperative ketoconazole therapy for adrenocortical carcinoma.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1989, Jul-15, Volume: 141, Issue:2

    Topics: Adrenal Cortex Neoplasms; Carcinoma; Combined Modality Therapy; Drug Evaluation; Female; Humans; Ket

1989
Use of ketoconazole in the treatment of a virilizing adrenocortical carcinoma.
    Acta endocrinologica, 1989, Volume: 121, Issue:2

    Topics: Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Carcinoma; Female; Gonadal Steroid Hormones; Hirs

1989
[Ketoconazole therapy of Cushing's syndrome caused by adrenal polyadenomatosis].
    Presse medicale (Paris, France : 1983), 1988, Feb-20, Volume: 17, Issue:6

    Topics: Adenoma; Adrenal Cortex Neoplasms; Cushing Syndrome; Humans; Ketoconazole; Male; Middle Aged

1988
Primary adrenocortical micronodular adenomatosis causing Cushing's syndrome. Effects of ketoconazole on steroid production and in vitro performance of adrenal cells.
    Acta endocrinologica, 1986, Volume: 113, Issue:3

    Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Captopril; Cushing Syndrome

1986